Literature DB >> 11757780

In vitro characterization of human intact erythrocytes loaded by enalaprilat.

M Hamidi1, H Tajerzadeh, A R Dehpour, M R Rouini, S Ejtemaee-Mehr.   

Abstract

In vitro characteristics of the human erythrocytes loaded by enalaprilat have been evaluated. Erythrocytes obtained from a healthy volunteer were loaded by enalaprilat using the hypotonic preswelling method, and the loading parameters, drug-release kinetics, hematological indices, particle size distribution, scanning electron microscopy view, osmotic and turbulence fragilities, and deformability of the resulting carrier cells were determined along with the sham encapsulated and unloaded cells. Carrier erythrocytes, having acceptable loading parameters, released their drug content according to zero-order kinetics. Mean corpuscular hemoglobin and mean corpuscular hemoglobin content values of the cells decreased, particle size dispersion increased, the cells transformed to cup-form, the erythrocytes became more fragile against osmotic pressure and turbulent flow, and, finally, the deformability of the cells decreased significantly upon drug loading.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757780     DOI: 10.1080/107175401317245903

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  11 in total

1.  Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel.

Authors:  Gamaleldin I Harisa; Mohamed F Ibrahim; Fars Alanazi; Gamal A Shazly
Journal:  Saudi Pharm J       Date:  2013-01-07       Impact factor: 4.330

Review 2.  Bio-inspired, bioengineered and biomimetic drug delivery carriers.

Authors:  Jin-Wook Yoo; Darrell J Irvine; Dennis E Discher; Samir Mitragotri
Journal:  Nat Rev Drug Discov       Date:  2011-07-01       Impact factor: 84.694

3.  Characterization of diadzein-hemoglobin binding using optical spectroscopy and molecular dynamics simulations.

Authors:  Bidisha Sengupta; Sandipan Chakraborty; Maurice Crawford; Jasmine M Taylor; Laura E Blackmon; Pradip K Biswas; Wolfgang H Kramer
Journal:  Int J Biol Macromol       Date:  2012-05-16       Impact factor: 6.953

4.  Engineering of erythrocyte-based drug carriers: control of protein release and bioactivity.

Authors:  Rongcong Luo; Shaillender Mutukumaraswamy; Subbu S Venkatraman; Björn Neu
Journal:  J Mater Sci Mater Med       Date:  2011-11-18       Impact factor: 3.896

5.  L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL).

Authors:  Young Min Kwon; Hee Sun Chung; Cheol Moon; James Yockman; Yoon Jeong Park; Scott D Gitlin; Allan E David; Victor C Yang
Journal:  J Control Release       Date:  2009-07-03       Impact factor: 9.776

Review 6.  Co-opting biology to deliver drugs.

Authors:  Parisa Yousefpour; Ashutosh Chilkoti
Journal:  Biotechnol Bioeng       Date:  2014-07-21       Impact factor: 4.530

7.  Characterization of human erythrocytes as potential carrier for pravastatin: an in vitro study.

Authors:  Gamal El-din I Harisa; Mohamed F Ibrahim; Fars K Alanazi
Journal:  Int J Med Sci       Date:  2011-03-11       Impact factor: 3.738

Review 8.  Cell or cell membrane-based drug delivery systems.

Authors:  Songwei Tan; Tingting Wu; Dan Zhang; Zhiping Zhang
Journal:  Theranostics       Date:  2015-04-27       Impact factor: 11.556

Review 9.  Drug-loaded erythrocytes: on the road toward marketing approval.

Authors:  Vanessa Bourgeaux; José M Lanao; Bridget E Bax; Yann Godfrin
Journal:  Drug Des Devel Ther       Date:  2016-02-11       Impact factor: 4.162

10.  GPMVs in variable physiological conditions: could they be used for therapy delivery?

Authors:  Špela Zemljič Jokhadar; Urška Klančnik; Maja Grundner; Tjaša Švelc Kebe; Saša Vrhovec Hartman; Mirjana Liović; Jure Derganc
Journal:  BMC Biophys       Date:  2018-01-03       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.